UHAL-B(UHAL-B)
UHAL-B
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for UHAL-B
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $6.27B | $6.46B |
| Low | $6.22B | $6.43B |
| High | $6.33B | $6.49B |
| EBITDA Avg | $2.15B | $2.22B |
| Low | $2.14B | $2.21B |
| High | $2.17B | $2.23B |
| EBIT Avg | $1.17B | $1.21B |
| Low | $1.16B | $1.20B |
| High | $1.18B | $1.21B |
| Net Income Avg | $255M | — |
| Low | $254M | — |
| High | $256M | — |
| EPS Avg | $1.30 | — |
| Low | $1.29 | — |
| High | $1.31 | — |
| Analysts (Rev / EPS) | 2 / 1 | 1 / — |
| Metric | Q2 2026 | Q3 2026 |
|---|---|---|
| Revenue Avg | $1.68B | $1.79B |
| Low | $1.66B | $1.76B |
| High | $1.69B | $1.81B |
| EBITDA Avg | $576M | $615M |
| Low | $571M | $606M |
| High | $581M | $623M |
| EBIT Avg | $314M | $335M |
| Low | $311M | $330M |
| High | $317M | $340M |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 2 / — | 2 / — |